Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

? Special Offer?Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

? New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Dusigitumab Biosimilar – Anti-IGF1, IGF2 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG2-nd

€200.00

100ug +200 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
Dusigitumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade

Dusigitumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade

Product name Dusigitumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade
Source CAS 1204390-13-5
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Dusigitumab,MEDI-573,IGF1, IGF2,anti-IGF1, IGF2
Reference PX-TA1310
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG2-nd
Clonality Monoclonal Antibody
Product name Dusigitumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade
Source CAS 1204390-13-5
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Dusigitumab,MEDI-573,IGF1, IGF2,anti-IGF1, IGF2
Reference PX-TA1310
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG2-nd
Clonality Monoclonal Antibody

General information on Anti-IGF1/IGF2[Homo sapiens] (Dusigitumab) Monoclonal Antibody

Dusigitumab has been investigated for the treatment of Cancer, Advanced Solid Malignancies, Unresectable or Metastatic Hepatocellular Carcinoma (HCC), and Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer.

There are no reviews yet.

Be the first to review “Dusigitumab Biosimilar – Anti-IGF1, IGF2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products